L. Tran

Characterization of an amorphous iridium water-oxidation catalyst electrodeposited from organometallic precursors.

James D. Blakemore, Steven J. Konezny, Robert C. Snoeberger, 2013, Inorganic chemistry.

Analysis of strongly absorbing chromophores by UV-visible ATR spectroscopy

W. M. Doyle, L. Tran, 2006 .

Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors.

D. K. Treiber, Zdravko V. Milanov, R. Armstrong, 2011, Bioorganic & medicinal chemistry letters.

Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E.

A. Ghose, Brian T. Campbell, Raffaella Faraoni, 2012, Journal of medicinal chemistry.

4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors.

Brian T. Campbell, Raffaella Faraoni, Andiliy G. Lai, 2011, Bioorganic & Medicinal Chemistry Letters.

Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E.

A. Ghose, Brian T. Campbell, Raffaella Faraoni, 2012, Journal of medicinal chemistry.